Home
>
National Drug Code (NDC)
>
Orphenadrine Citrate
Orphenadrine Citrate - 0115-2011-01 - (ORPHENADRINE CITRATE)
Drug Information of Orphenadrine Citrate
| Product NDC: | 0115-2011 |
| Proprietary Name: | Orphenadrine Citrate |
| Non Proprietary Name: | ORPHENADRINE CITRATE |
| Active Ingredient(s): | 100 mg/1 & nbsp; ORPHENADRINE CITRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Orphenadrine Citrate
| Product NDC: | 0115-2011 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040368 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000623 |
Package Information of Orphenadrine Citrate
| Package NDC: | 0115-2011-01 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-2011-01) |
NDC Information of Orphenadrine Citrate
| NDC Code | 0115-2011-01 |
| Proprietary Name | Orphenadrine Citrate |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-2011-01) |
| Product NDC | 0115-2011 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ORPHENADRINE CITRATE |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20000623 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | ORPHENADRINE CITRATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
